(Q46438870)

22 December 2017

title

Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans (English)

1 reference

22 December 2017

1 reference

Chun-Su Yuan

1

1 reference

22 December 2017

Harold Doshan

2

1 reference

22 December 2017

Martha R Charney

3

1 reference

22 December 2017

Michael O'connor

4

1 reference

22 December 2017

Theodore Karrison

5

1 reference

22 December 2017

S A Maleckar

6

1 reference

22 December 2017

Robert J Israel

7

1 reference

22 December 2017

Jonathan Moss

8

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

22 December 2017

volume

45

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

538-546

1 reference

22 December 2017

The use of quaternary narcotic antagonists in opiate research

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Opioid-induced delay in gastric emptying: a peripheral mechanism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Oral methylnaltrexone for opioid-induced constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Selective postoperative inhibition of gastrointestinal opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

The current status of opioid research on gastrointestinal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

The central and peripheral influences of opioids on gastrointestinal propulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Insights into opioid action in the intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Oral morphine in chronic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Unrecognized constipation in patients with advanced cancer: a recipe for therapeutic disaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Naloxone treatment for irritable bowel syndrome--a randomized controlled trial with an oral formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Anxiety and pain: attentional and endorphinergic influences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Non-specific effect of naltrexone on ethanol consumption in social drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Opioid antagonists for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273491

21 January 2018

Identifiers

DOI

10.1177/0091270004273491

1 reference

22 December 2017

release_5tdqlcyy6zgcjaeswonzmoj47y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5tdqlcyy6zgcjaeswonzmoj47y

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15831777

1 reference

22 December 2017